Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × relatlimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Melanoma 23 Neoplasms 7 Recurrence 5 Carcinoma, Hepatocellular 5 Stomach Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Advanced Cancer 4 Uveal Melanoma 3 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Liver Neoplasms 3 Colonic Neoplasms 3 Rectal Neoplasms 2 Ovarian Neoplasms 2 Neoplasms by Site 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Glioma 2 Glioblastoma 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Renal Cell 2 Carcinoma, Basal Cell 2 Brain Neoplasms 2

Interventions

Cytarabine 559 Azacitidine 379 venetoclax 306 Cyclophosphamide 284 fludarabine 239 fludarabine phosphate 227 Decitabine 186 Busulfan 172 Daunorubicin 153 Idarubicin 149 Peripheral Blood Stem Cell Transplantation 137 Filgrastim 134 Whole-Body Irradiation 132 Mycophenolic Acid 132 Granulocyte Colony-Stimulating Factor 124 Tacrolimus 122 Etoposide 117 Mitoxantrone 103 Methotrexate 103 Melphalan 101 Cyclosporine 100 Gemtuzumab 84 Antilymphocyte Serum 84 Clofarabine 83 Specimen Handling 69 Injections 69 Stem Cell Transplantation 63 CPX-351 56 Biopsy 54 Thiotepa 51

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04913922 2022-11-08

AARON

Ludwig-Maximilians - University of Munich

Phase 2 Unknown

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡